I swore to myself on a stack of bibles that I would never reply directly to a post by this person (JT), but when they post such utter rubbish I cannot control myself.(sarc). Their reference to the lithium price is a complete joke, compared to other lithium companies our cash cost for the life of our mine is US$281 per tonne of concentrate see below taken from link to our DFS (link provided)
https://malilithium.com/pdfs/GoulaminaLithiumProjectDefinitiveFeasibilityStudy20Oct20.pdf
Mali Lithium Limited to be renamed FireFinch (ASX: FFX) (MLL or the Company), is pleased to announce
the results of the Goulamina Lithium Project (Goulamina or the Project) Definitive Feasibility Study (DFS).
Key metrics are:
Mineral Resources (M,I&I) 108.5 million tonnes at 1.45% Li2O
Mine Life 23 years minimum
Ore Reserves (Proven and Probable) 52 million tonnes at 1.51 % Li2O
Average Spodumene concentrate production 436,000 tonnes per annum
Concentrate specifications 6% Li2O, <0.6%Fe2O3, low mica
Annual Mine throughput 2.3 million tonnes
Pre-tax NPV (8%) at $666/tonne concentrate Approx. A$1.7 billion (US$1.2billion)
Pre-tax IRR 55.8%
Capital Cost US$194 million
Cash Costs (Life of Mine) US$281 per tonne concentrate
All in sustaining cost (AISC) Years 1-5 US$306 per tonne concentrate
Now can the poster answer why all other lithium stocks are racing ahead when their cash costs are higher than ours. They would kill to have our cost base. Some people just post absolute rubbish.
Hold them tight people.....very interesting times ahead...............Oh and don't forget about our gold mine
All imo and DYOR
- Forums
- ASX - By Stock
- FFX
- Ann: Satellite Pit Resources update delivers 1.49M oz of gold
Ann: Satellite Pit Resources update delivers 1.49M oz of gold, page-51
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online